搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
5 天
on MSN
Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...
5 天
on MSN
Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?
We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look ...
technologynetworks
8 小时
Biotech and Pharma Aim for Net Zero, But Their Supply Chains Lag
According to an annual report by My Green Lab, the biotech and pharmaceutical sectors still have some supply chain hurdles to ...
Yahoo Finance
5 天
Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against the ...
11 天
The Role of Laboratory Freeze Dryers in Pharmaceutical and Biotech Research
Pharmaceutical and biotech industries essentially use laboratory freeze dryers in their research. Such equipment is employed ...
BioPharma Dive
17 小时
Roche to buy cell therapy developer Poseida for $1B
The deal suggests Roche sees substantial promise in Poseida’s technology, as the offer is 215% above the biotech’s closing ...
17 小时
Invesco Health Care Fund Q3 2024 Commentary
Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is ...
4 天
Got $500? 1 Biotech Stock to Buy and Hold Forever
If you have $500, you should check out Vertex Pharmaceuticals ( VRTX 0.13%). Here's why this biotech stock is a great ...
14 小时
Healthy Returns: Trump's FDA pick Makary may be a relief for biotech and pharma, analysts say
Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈